Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

We are fascinated by science and we are committed to help the best innovators in addressing strong unmet clinical needs, spanning from rare diseases to oncology, immunology and other life threatening disease areas. 

We provide capital, competence and hands-on support to jump start clinical development programs and pursue value creation based on clinical evidence.